Radiation Detection Monitoring and Safety Market Comprehensive Review of its Applications Growth Opportunities and Future Prospects
Increasing use of radiation therapy for treatment and
diagnosis purposes is expected to fuel the growth of the medical
radiation detection, monitoring and safety market. According to the
National Health Service (NHS), there were 41.4 million imaging tests reported
in England between December 2016 to November 2017. Of these, 3.6 million
imaging tests were performed in November 2017. During this period, X-ray
examinations were conducted at a large-scale, as compared to ultrasound,
computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans.
Geographically, North America is expected to lead the
radiation detection, monitoring and safety industry in the coming years,
primarily due to the improving nuclear power industry, and increasing number of
nuclear weapon research activities, and development centers in the region.
Moreover, the stiffer regulations for these products in North America also
supports the regional market growth.
The radiation detection, monitoring and safety market is
expected to witness the fastest growth in Asia-Pacific (APAC) during the
forecast period. This is primarily characterized by the ongoing expansion in
the nuclear power production capacity in the developing countries of the
region. Emerging countries, such as China, India, and Indonesia, have
introduced many new proposals to expand the manufacturing capacity for nuclear
power generation, which is expected to boost the growth of the APAC market in
the coming years.
Rising prevalence of cancer, increasing safety awareness
among people working in radiation-prone environment, growing safety concerns
after the Fukushima disaster, spur in the number of PET/CT scans, increasing
adoption of nuclear medicine and radiation therapy for diagnosis and treatment
of various diseases, and use of drones for radiation monitoring are some of the
elements driving the growth of the radiation detection, monitoring and safety
market.
Request to Get the Sample Pages at:
Ongoing partnerships and product launches by the players in
the radiation detection, monitoring and safety market are expected to increase
their market share in the coming years. For instance, in October 2018, DiaCarta
Inc., a diagnostic company and developer of products for nucleic acid-based
detection assays, received $2 million through National Cancer Institute (NCI)
Small Business Innovation Research (SBIR) contract to continue development of
its RadToxTM cfDNA radiation therapy toxicity monitoring test kit for cancer
patients.
Other than DiaCarta Inc., the radiation detection
monitoring, and safety industry includes players such as Thermo Fischer
Scientific Inc., AMETEK Inc., Fluke Corporation, ATOMTEX, Arktis Radiation Detectors
Ltd., Mirion Technologies Inc., Comecer S.p.A., Fuji Electric Co. Ltd., General
Electric Company, and Smiths Group.
The market study provides historical as well the forecast
data for various geographies including the U.S., Canada, Germany, U.K., France,
Italy, Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa.
Comments
Post a Comment